HEALTHY Study Rationale, Design and Methods: Moderating Risk of Type 2 Diabetes in Multi-Ethnic Middle School Students In this supplement the authors and study group present the rationale and design ...
Intermittent Treatment With MEK Inhibitors in Patients With Oncogenic RAF-Driven Tumors: A Potential Strategy to Manage Toxicity and Maintain Efficacy Case reports and small prospective trials suggest ...
PARIS AND PRINCETON, N.J.-- (BUSINESS WIRE)--Sanofi-aventis (NYSE: SNY) and Bristol-Myers Squibb Company (NYSE: BMY) announced today that the American Heart Journal published the rationale and design ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results